|
Feb 28
|
Standard BioTools Inc (LAB) Reports Growth and Margin Expansion in FY2023 Despite Economic ...
|
|
Feb 28
|
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results
|
|
Feb 26
|
Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing
|
|
Dec 29
|
Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
|
|
Dec 28
|
Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioTools
|
|
Dec 26
|
SomaLogic Issues Statement Correcting Madryn Asset Management's Misleading Disclosure
|
|
Dec 22
|
ISS Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
|
|
Dec 21
|
SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools
|
|
Dec 20
|
Skye Fund III Issues Letter Regarding Opposition to SomaLogic’s Proposed Merger with Standard BioTools
|
|
Dec 4
|
Standard BioTools and SomaLogic Announce Date for Special Meetings of Stockholders to Vote on Proposed Merger
|
|
Dec 2
|
Standard BioTools Inc. (NASDAQ:LAB) has caught the attention of institutional investors who hold a sizeable 44% stake
|
|
Nov 9
|
Q3 2023 Somalogic Inc Earnings Call
|
|
Nov 8
|
Standard BioTools Inc. (NASDAQ:LAB) Q3 2023 Earnings Call Transcript
|
|
Nov 8
|
Q3 2023 Standard BioTools Inc Earnings Call
|
|
Nov 7
|
Standard BioTools Reports Third Quarter and Year-to-Date 2023 Financial Results
|